CLYYF
Price:
$0.18
Market Cap:
$8.28M
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical trial to treat relapsed / refractory multiple myeloma; and CYAD-02, an autologous CAR-T candidate that is in Phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes. The company's precl...[Read more]
Industry
Biotechnology
IPO Date
2014-01-15
Stock Exchange
OTC
Ticker
CLYYF
According to Celyad Oncology S.A.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Celyad Oncology S.A. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CLYYF's Dividend Yield was at its highest in in the June 2010 quarter at 0%. The Dividend Yield was at its lowest in in the June 2010 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Celyad Oncology S.A. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
The current Dividend Yield of Celyad Oncology S.A. (CLYYF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Celyad Oncology S.A.’s Dividend Yield is less than ERYTECH Pharma S.A. (0%), less than Molecular Partners AG (0%), less than XORTX Therapeutics Inc. (0%), less than Nutriband Inc. (0%), less than YS Biopharma Co., Ltd. (0%), less than Sonnet BioTherapeutics Holdings, Inc. (0%), less than ZyVersa Therapeutics, Inc. (0%), less than Allarity Therapeutics, Inc. (0%), less than Kiromic BioPharma, Inc. (0%), less than Claritas Pharmaceuticals, Inc. (0%), less than Intellipharmaceutics International Inc. (0%), less than Metacrine, Inc. (0%), less than ForU Holdings, Inc. (0%), less than ChitogenX Inc. (0%), less than Aditxt, Inc. (0%), less than Palisade Bio, Inc. (0%), less than Plus Therapeutics, Inc. (0%), less than Revelation Biosciences, Inc. (0%), less than Quoin Pharmaceuticals, Ltd. (0%), less than Virax Biolabs Group Limited (0%), less than Blue Water Vaccines, Inc. (0%), less than Hillstream BioPharma, Inc. (0%), less than Kiora Pharmaceuticals, Inc. (0%), less than null (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $47.38M | |
| 0% | $162.53M | |
| 0% | $2.50M | |
| 0% | $56.16M | |
| 0% | $192.09M | |
| 0% | $8.43M | |
| 0% | $1.13M | |
| 0% | $16.78M | |
| 0% | $214.93K | |
| 0% | $3.66K | |
| 0% | $4.96M | |
| 0% | $0 | |
| 0% | $2.17K | |
| 0% | $301.50K | |
| 0% | $67.56K | |
| 0% | $262.99M | |
| 0% | $39.67M | |
| 0% | $6.22M | |
| 0% | $7.89M | |
| 0% | $2.65M | |
| 0% | $3.41M | |
| 0% | $4.17M | |
| 0% | $7.67M | |
| 0% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celyad Oncology S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Celyad Oncology S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Celyad Oncology S.A.'s Dividend Yield?
How is the Dividend Yield calculated for Celyad Oncology S.A. (CLYYF)?
What is the highest Dividend Yield for Celyad Oncology S.A. (CLYYF)?
What is the 3-year average Dividend Yield for Celyad Oncology S.A. (CLYYF)?
What is the 5-year average Dividend Yield for Celyad Oncology S.A. (CLYYF)?
How does the current Dividend Yield for Celyad Oncology S.A. (CLYYF) compare to its historical average?